Search clinical trials for: non alcoholic fatty liver disease
Total 389675 results
-
89bio, Inc.ProSciento, Inc.Completed
-
Zagazig UniversityCompleted
-
Oramed, Ltd.CompletedNonalcoholic Steatohepatitis (NASH)Belgium
-
Nanfang Hospital, Southern Medical UniversityCompleted
-
Ionis Pharmaceuticals, Inc.CompletedSteatohepatitis, NonalcoholicUnited States, Puerto Rico
-
University of FloridaInventiva PharmaCompletedNonalcoholic Fatty Liver Disease (NAFLD) | Type 2 Diabetes (T2DM)United States
-
Metacrine, Inc.Completed
-
Ohio State UniversityActive, not recruiting
-
Duke UniversityCompletedDiabetes Mellitus | NAFLDUnited States
-
University of AarhusDanish Diabetes AcademyCompletedType 2 Diabetes | NAFLDDenmark
-
AstraZenecaCompletedNon-alcoholic Fatty Liver Disease | NAFLD | Nonalcoholic Fatty Liver Disease | Nonalcoholic Steatohepatitis | NASH | Fatty Liver, NonalcoholicUnited States
-
Fondazione Policlinico Universitario Agostino Gemelli...Active, not recruitingDiabetes | NAFLD | Fibrosis, Liver | Cirrhosis, Liver | Liver Cancer | NASHItaly
-
Hospital General de MexicoWithdrawnNon-alcoholic SteatohepatitisMexico
-
J2H BiotechCompletedNon-alcoholic SteatohepatitisKorea, Republic of
-
Assistance Publique - Hôpitaux de ParisCompletedNonalcoholic Fatty Liver Disease (NAFLD)France
-
Oramed, Ltd.Hadassah Medical OrganizationCompletedType2 Diabetes Mellitus | Non-Alcoholic Steatohepatitis (NASH)Israel
-
J2H BiotechCompletedNon-alcoholic SteatohepatitisKorea, Republic of
-
Joslin Diabetes CenterActive, not recruitingType 1 Diabetes | Fibrosis, Liver | Nonalcoholic Steatohepatitis | Cirrhosis, Liver | Nonalcoholic Fatty LiverUnited States
-
Alnylam PharmaceuticalsTerminatedNonalcoholic Steatohepatitis | NASHUnited States, Bulgaria, United Kingdom, Belgium, Turkey
-
Imperial College LondonKing's College LondonCompletedNon-Alcoholic Fatty Liver Disease | Fecal Microbiota TransplantationUnited Kingdom
-
Washington University School of MedicineEnrolling by invitationNon-Alcoholic Fatty Liver DiseaseUnited States
-
University of Alabama at BirminghamAstraZenecaTerminatedNon-alcoholic Fatty Liver Disease (NAFLD) | Non-alcoholic Steatohepatitis (NASH)United States
-
Rivus Pharmaceuticals, Inc.CompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
Novo Nordisk A/SCompleted
-
Hasselt UniversityActive, not recruiting
-
HaEmek Medical Center, IsraelCompletedNon-alcoholic Fatty Liver Disease | Liver FibrosisIsrael
-
Novartis PharmaceuticalsTerminatedPlaque Psoriasis | Non-alcoholic Fatty Liver DiseaseGermany, Spain
-
Guangzhou Medical UniversityAffiliated Hospital of Guangdong Medical UniversityCompletedNonalcoholic Fatty Liver DiseaseChina
-
Gilead SciencesNovo Nordisk A/SActive, not recruitingNonalcoholic SteatohepatitisUnited States, Spain, Australia, France, Japan, Puerto Rico, Canada
-
AstraZenecaActive, not recruitingNon-alcoholic Steatohepatitis (NASH)United States
-
Fundació EurecatCentre de Diagnosi per la Imatge; Laboratorio de Referencia Sud; Centro OWLiverCompletedNon-Alcoholic Fatty Liver Disease | Visceral ObesitySpain
-
Inventiva PharmaActive, not recruitingDiabetes Mellitus, Type 2 | NASH - Nonalcoholic SteatohepatitisUnited States, Belgium, France, Netherlands, United Kingdom
-
European Organisation for Research and Treatment...Active, not recruitingLymphomaFrance, Poland, Belgium, Netherlands, Slovenia, Italy, Egypt, Portugal, Germany
-
GenieBiome LimitedCompletedNon-Alcoholic Fatty Liver DiseaseHong Kong
-
Sunshine Lake Pharma Co., Ltd.CompletedNon-Alcoholic SteatohepatitisChina
-
Taipei City HospitalThe One Biopharmaceutical Co., Ltd.CompletedNon-alcoholic Fatty Liver Disease | Liver Fibrosis | Liver InjuryTaiwan
-
Ewha Womans University Mokdong HospitalCompletedNonalcoholic Steatohepatitis | Nonalcoholic Fatty LiverKorea, Republic of
-
Arkansas Children's Hospital Research InstituteNational Institute of General Medical Sciences (NIGMS)CompletedHigh Intensity Interval Training | Insulin Resistance | Childhood Obesity | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Madrigal Pharmaceuticals, Inc.Active, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Spain, Australia, United Kingdom, Canada, Israel, Belgium, Italy, France, Puerto Rico, Switzerland, Germany, Austria, Poland, Mexico, Hungary
-
PfizerCompletedHepatic Impairment | Healthy ParticipantsCzechia, Slovakia, Belgium
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingNonalcoholic Fatty Liver Disease | PhysicianUnited States
-
Bristol-Myers SquibbTerminatedNonalcoholic Steatohepatitis (NASH)United States, Germany, Taiwan, United Kingdom, Spain, Argentina, Brazil, France, Israel, Italy, Japan, Korea, Republic of, Belgium, Canada, Puerto Rico, Switzerland
-
89bio, Inc.Active, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Puerto Rico
-
Sisli Hamidiye Etfal Training and Research HospitalCompletedNAFLD | Obesity, ChildhoodTurkey
-
COD Research Private LtdCompletedFatty Liver Without Mention of AlcoholIndia
-
Chinese University of Hong KongTerminatedNon-alcoholic Fatty Liver DiseaseHong Kong
-
AdventHealth Translational Research InstituteActive, not recruitingNon-Alcoholic Fatty Liver DiseaseUnited States
-
Cambridge University Hospitals NHS Foundation TrustUniversity of CambridgeTerminatedCardiovascular DiseasesUnited Kingdom
-
Sadat City UniversityActive, not recruitingFatty Liver, NonalcoholicEgypt